Daniel O’Day: Investments in education are investments in the future
Daniel O’Day, Chairman and Chief Executive Officer of Gilead Sciences and Board Member of PhRMA and Galapagos, shared a post on LinkedIn:
“Investments in education are investments in the future.
That’s why Gilead Sciences and the Gilead Foundation are proud to support San Francisco State University as it empowers the next generation of STEM leaders through our $5M grant.
It was a pleasure to join the dedication ceremony for the new Science & Engineering Innovation Center and to meet the passionate leaders who brought their vision for the center to life. It marks a major step forward for SF State.
Equipped with state-of-the-art labs, this facility will train students in essential biopharma, biotech, and engineering skills, advancing our shared commitment to health equity and workforce diversity.
A big thank you to the SF State team and other partners, including Lynn Mahoney, Carmen Domingo, Catherine Stefani, and Rafael Mandelman for making this vision a reality.
Learn more about our partnership and bold vision here.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023